main reservoir for influenza A viruses, as well as in pigs, a mammalian species that is susceptible to both avian and human influenza A viruses. 4, 5 For 40 years, since 1977, the 2 influenza A virus subtypes, H1N1 and H3N2, have been cocirculating with influenza B viruses in the human population, and all 3 viruses have undergone significant evolution through antigenic drift over time. 6 Occasionally an animal influenza A virus or an animal-human reassortant influenza A virus may cause infection in humans who have had contact with infected animals. 4 If such a virus readily replicates in humans, and this virus acquires the ability to spread from human to human in the absence of immunity in large segments of the human population, such a virus may cause a global pandemic. Although influenza pandemics obviously have stricken humanity throughout history, the first convincing historical evidence for an influenza pandemic is from 1580. Before the late 19th century, 3 additional influenza pandemics were identified through accurate clinical and epidemiological descriptions in historical records. 7 Precise laboratory evidence is available only for the 4 pandemics that occurred after 1917.
| DE VELOPMENTSLE AD INGUPTOTHE FOUND INGOFTHEG IS R S(1947-1952)
Memories of the devastating impact of the Spanish flu pandemic in 1918 were still vividly present in the minds of the medical and scientific experts as well as the public when the first experiments with influenza vaccines were undertaken only a few years after the first human influenza viruses were isolated. 8 The growing understanding that annual influenza epidemics can contribute to significant morbidity and mortality in the population and the fear of another severe pandemic stimulated vaccine research. In the early 1940s, techniques for the isolation of influenza viruses in embryonated hens' eggs were refined, which opened the door for more systematic and larger vaccine trials. During these years, descendants of the influenza A(H1N1) viruses that had swept the world in 1918 continued to cocirculate with influenza B viruses, causing annual epidemics of varying severity. Some of the early vaccine trials showed promising results which resulted in approval of the first influenza vaccines in the United States.
In 1946, the United Nations assigned an Interim Commission with the task to develop an initial program to establish the World Health Organization (WHO). During a session of this Interim Commission in early 1947, the public health threat posed by influenza was discussed and it was decided to form a special committee on influenza in order to work out guidelines for influenza surveillance. Coincidentally, it was observed that the seasonal vaccine used in military populations in the United States in 1947 provided no significant protection against the epidemic virus. 9 Characterization of the circulating virus with hemagglutination inhibition (HI) tests revealed significant antigenic differences between the vaccine virus and the epidemic virus, shed light on the rapid evolution of influenza viruses and further established a need for ongoing global influenza surveillance for both seasonal and pandemic influenza viruses. Within a short time, 12 The same year, the Bulletin of the WHO devoted an entire issue to influenza, underlining the importance of this common disease. 13 During these years, an increasing understanding of the health burden caused by influenza viruses, widening insight into the biology of these viruses and their antigenic diversity reinforced the need for systematic surveillance of globally circulating influenza viruses to mount an appropriate, timely response to seasonal and pandemic influenza.
| T WODEC ADE SAND2INFLUENZ A PANDEMI C S(1953-1972)
When the GISRS was established in 1952, 25 countries already had some influenza surveillance in place and were able to report data to WHO, and contributing laboratories in these countries were later recognized by WHO as National Influenza Centers (NICs 
| ANOTHER2 0YE AR S-THE REEMERG EN CEOFINFLUENZ AA(H1N1) VIRUS E SANDD IVERG EN CEOFINFLUENZ A BVIRUS E S(1973-1992)
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| PANDEMI CTHRE ATS ,PANDEMI C PREPAREDNE SS ,ANDAPANDEMIC(1993-2 017)
Twenty-five years after the 1968 pandemic, the influenza community and public health experts agreed that it is not a question whether but rather when a next pandemic will happen. This thought catalyzed national and international activities toward better preparedness for the event of an influenza pandemic. In the early 1990s, accumulating data revealed that the death toll from the "Spanish Flu" pandemic in 1918 had been significantly higher than assumed previously. In light of these new estimates of mortality and a better understanding of the evolution and ecology of influenza, the scientific community concluded that a similarly devastating influenza pandemic in the future could not be excluded. In several countries, groups of experts in different fields, including scientists from GISRS laboratories, started to develop strategies to help minimizing 
